Senior insider sale
Chief Commercial Officer at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$15.43M
212.07K shares
What this filing means
MOTTIWALA AZIZ plans to sell 212.07K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $15.43M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/1/2026ACC: 0001959173-26-006607
Officer· Chief Commercial Officer
Since Oct 2020
212.07K
Shares to sell
$15.43M
Approx. market value
77.70K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
9/1/2026
77.70KTotal acquired77.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2026 | Stock Option Exercise Cash | 77.70K | — |
| Total | 77.70K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
81.33K
Market value
$5.84M
8/25/2026
—Completed
Units to sell
53.04K
Market value
$3.84M
8/19/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
77.70K
Market value
$5.75M
9/1/2026
Total
Units
212.07K
Value
$15.43M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/25/2026 | 81.33K | $5.84M | — | Completed |
8/19/2026 | 53.04K | $3.84M | — | Completed |
| Planned — Approximate Date | ||||
9/1/2026 | 77.70K | $5.75M | NASDAQ | Planned |
| Total | 212.07K | $15.43M | ||